Jiangsu Hengrui Pharmaceuticals (01276) invested 6.794 million yuan on August 12 to repurchase 125,000 shares of A-shares.
Hengrui Medicine (01276) announced that the company has repurchased 125,000 A shares for a total cost of 6.794 million RMB on August 12, 2026, with a repurchase price of 54.15-54.41 RMB per share.
Jiangsu Hengrui Pharmaceuticals (01276) announced that the company will spend 6.794 million yuan to repurchase 125,000 A-shares on August 12, 2026, with a repurchase price ranging from 54.15 to 54.41 yuan per share.
Related Articles
ASIASEC PPT (00271) issues a profit warning, expecting a net loss of approximately HKD 110 million to HKD 120 million for the interim period.
ZHIHU-W (02390) repurchased 95,100 shares on August 11 for a total of $104,700.
BEKE-W (02423) spent 3 million US dollars to repurchase 529,900 shares on August 11.
ASIASEC PPT (00271) issues a profit warning, expecting a net loss of approximately HKD 110 million to HKD 120 million for the interim period.
ZHIHU-W (02390) repurchased 95,100 shares on August 11 for a total of $104,700.
BEKE-W (02423) spent 3 million US dollars to repurchase 529,900 shares on August 11.
RECOMMEND
